PT80635A - Process for the preparation of a new galenic form with retard - Google Patents

Process for the preparation of a new galenic form with retard

Info

Publication number
PT80635A
PT80635A PT80635A PT8063585A PT80635A PT 80635 A PT80635 A PT 80635A PT 80635 A PT80635 A PT 80635A PT 8063585 A PT8063585 A PT 8063585A PT 80635 A PT80635 A PT 80635A
Authority
PT
Portugal
Prior art keywords
retard
preparation
galenic form
new galenic
new
Prior art date
Application number
PT80635A
Other languages
Portuguese (pt)
Other versions
PT80635B (en
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT80635A publication Critical patent/PT80635A/en
Publication of PT80635B publication Critical patent/PT80635B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT80635A 1984-06-14 1985-06-12 PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT PT80635B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (2)

Publication Number Publication Date
PT80635A true PT80635A (en) 1985-07-01
PT80635B PT80635B (en) 1987-10-20

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80635A PT80635B (en) 1984-06-14 1985-06-12 PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490A0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US6093420A (en) 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
EP1189599A2 (en) * 1999-06-11 2002-03-27 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
AU769807B2 (en) * 1999-08-04 2004-02-05 Astellas Pharma Inc. Stable medicinal compositions for oral use
NZ511900A (en) 1999-09-30 2003-06-30 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
KR20040058103A (en) * 2001-02-13 2004-07-03 아스트라제네카 아베 Novel Modified Release Formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8956602B2 (en) 2006-12-05 2015-02-17 Landec, Inc. Delivery of drugs
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
CA2734646C (en) 2008-08-20 2016-06-28 James W. Mcginity Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DK149855C (en) * 1977-06-20 1987-04-21 Sandoz Ag METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DK154607C (en) * 1978-12-21 1989-06-05 Sandoz Ag PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (en) * 1981-10-29 1993-02-10 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION

Also Published As

Publication number Publication date
ATA174885A (en) 1990-06-15
NL8501578A (en) 1986-01-02
SE504583C2 (en) 1997-03-10
DE3520184C2 (en) 1997-03-13
GB8727055D0 (en) 1987-12-23
SE8502950D0 (en) 1985-06-13
IE58834B1 (en) 1993-11-17
NL194389C (en) 2002-03-04
LU85946A1 (en) 1986-01-24
GB2196852B (en) 1989-05-17
FR2565822B1 (en) 1989-02-17
NZ212390A (en) 1992-02-25
CY1635A (en) 1992-11-06
ES544075A0 (en) 1987-01-01
AU4454389A (en) 1990-03-22
HUT40918A (en) 1987-03-30
IT1200080B (en) 1989-01-05
AT391806B (en) 1990-12-10
DK264785D0 (en) 1985-06-12
DE3520184A1 (en) 1985-12-19
IL75490A0 (en) 1985-10-31
GB2196852A (en) 1988-05-11
GB2160100B (en) 1989-06-01
NL194389B (en) 2001-11-01
GR851430B (en) 1985-11-25
GB8514855D0 (en) 1985-07-17
ES8702141A1 (en) 1987-01-01
DK264785A (en) 1985-12-15
CA1264441A (en) 1990-01-16
AU587190B2 (en) 1989-08-10
AU4348685A (en) 1985-12-19
GB2196851B (en) 1989-06-07
GB2196851A (en) 1988-05-11
GB2160100A (en) 1985-12-18
HK25192A (en) 1992-04-10
HU198844B (en) 1989-12-28
PT80635B (en) 1987-10-20
IE851460L (en) 1985-12-14
BE902626A (en) 1985-12-10
GB8727056D0 (en) 1987-12-23
FR2565822A1 (en) 1985-12-20
SE8502950L (en) 1985-12-15
IT8548210A0 (en) 1985-06-13
DK167649B1 (en) 1993-12-06

Similar Documents

Publication Publication Date Title
PT80635A (en) Process for the preparation of a new galenic form with retard
EP0165537A3 (en) Process for the preparation of heteroaryloxyacetamides
PT80178B (en) Process for the preparation of substituted alpha-amino-acids
DE3571028D1 (en) A process for the preparation of p-isononanoyloxybenzenenesulphonate
PT81072A (en) Process for the preparation of a fungicidal composition with carbamoylimidazole derivatives
PT79818A (en) Process for the preparation of alpha-acetylamin-ergolines
HRP921043B1 (en) Process for the preparation of hydroxy-4-2h-1-benzothiopyrane-2-ones
PT81526A (en) Process for the preparation of new homopropargylamines
PT80919A (en) Process for the preparation of 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1h-indoles
GB2158824B (en) Process for the preparation of 2-amino-s-triazines
DE3570653D1 (en) Process for the preparation of beta-aminoethylketones
PT80999A (en) Process for the preparation of cyclimmonium salts
PT80634A (en) Process for the preparation of naftoxazines
DE3560592D1 (en) A process for the preparation of l-tryptophan
DE3570438D1 (en) A process for the preparation of bis-phosphineoxide compounds
DE3566249D1 (en) Process for the preparation of fluoroformiates
DE3560035D1 (en) Process for the preparation of 2-methyl-2-alkenals
EP0173202A3 (en) Process for the preparation of chloro-o-nitroanilines
EP0175364A3 (en) Process for the preparation of alpha-beta-diaminoacrylnitriles
EP0166214A3 (en) Process for the preparation of dialkylsuccinylsuccinat
ZA857285B (en) Process for the preparation of lime-nitrogen
ZA854520B (en) Novel galenic retard form
PT81765B (en) Process for the preparation of hydroxyaldheydes
PT79831B (en) Process for the preparation of cyanoethyled benzodiazephines
EP0178519A3 (en) Process for the preparation of dialkoxy-triazinyl-pyrenes

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 971017 NOVARTIS AG CH